<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Head and Neck Tumors</journal-id><journal-title-group><journal-title xml:lang="en">Head and Neck Tumors</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли головы и шеи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2222-1468</issn><issn publication-format="electronic">2411-4634</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">579</article-id><article-id pub-id-type="doi">10.17650/2222-1468-2020-10-4-32-43</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ ГОЛОВЫ И ШЕИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Transhyoid approach in surgical treatment of oropharyngeal carcinoma</article-title><trans-title-group xml:lang="ru"><trans-title>Чресподъязычный доступ в хирургическом лечении орофарингеального рака</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karpenko</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Карпенко</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>37–39 Liteyny Ave., Saint Petersburg 191104</p></bio><bio xml:lang="ru"><p>191014 Санкт-Петербург, Литейный просп., 37–39</p><p> </p><p> </p><p> </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sibgatullin</surname><given-names>R. R.</given-names></name><name xml:lang="ru"><surname>Сибгатуллин</surname><given-names>Р. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>37–39 Liteyny Ave., Saint Petersburg 191104</p></bio><bio xml:lang="ru"><p>191014 Санкт-Петербург, Литейный просп., 37–39</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Boyko</surname><given-names>А. А.</given-names></name><name xml:lang="ru"><surname>Бойко</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>37–39 Liteyny Ave., Saint Petersburg 191104</p></bio><bio xml:lang="ru"><p>191014 Санкт-Петербург, Литейный просп., 37–39</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kostova</surname><given-names>М. G.</given-names></name><name xml:lang="ru"><surname>Костова</surname><given-names>Г. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>37–39 Liteyny Ave., Saint Petersburg 191104</p></bio><bio xml:lang="ru"><p><bold>Мариана Георгиевна Костова </bold></p><p>191014 Санкт-Петербург, Литейный просп., 37–39</p></bio><email>kostova.90@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Leningrad Regional Oncologic Dispensary</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Ленинградский областной клинический онкологический диспансер»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-12-16" publication-format="electronic"><day>16</day><month>12</month><year>2020</year></pub-date><volume>10</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>32</fpage><lpage>43</lpage><history><date date-type="received" iso-8601-date="2021-01-15"><day>15</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-01-15"><day>15</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Karpenko A.V., Sibgatullin R.R., Boyko А.А., Kostova М.G.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Карпенко А.В., Сибгатуллин Р.Р., Бойко А.А., Костова Г.М.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Karpenko A.V., Sibgatullin R.R., Boyko А.А., Kostova М.G.</copyright-holder><copyright-holder xml:lang="ru">Карпенко А.В., Сибгатуллин Р.Р., Бойко А.А., Костова Г.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ogsh.abvpress.ru/jour/article/view/579">https://ogsh.abvpress.ru/jour/article/view/579</self-uri><abstract xml:lang="en"><p><bold>The study objective</bold> is to assess functional and oncologic results of transhyoid approach used for surgical treatment of oropharyngeal carcinoma.</p><p><bold>Materials and methods.</bold> Operative records, hospital charts and data from out-patient department of 55 patients (T1 – 6, T2 – 16, T3 – 19, T4 – 14) with oropharyngeal carcinoma operated via a transhyoid approach were reviewed. Postoperative period was reviewed for complications. All oncologic adverse events were registered with special emphasis on the rate of local recurrence. A univariate analysis with chisquare and Fisher’s exact test was used to check the correlation between tumor factors and surgical variables (complications, mode of reconstruction). The influence of tumor- and treatment-related variables (T stage, differentiation, perineural invasion, p16 status, depth of invasion, extension to the oral cavity, adjuvant treatment) on the rate of local recurrence was studied in the same way. The log-rank test was used to assess differences in survival curves. The data was compared with other series of patients treated with the same technique.</p><p><bold>Results.</bold> Seventeen (30,9 %) patients developed 29 complications. There was 1 postoperative death. Five (9,1 %) patients required repeated operation. The mode of reconstruction (primary closure vs flaps) was a major factor influencing the rate of complications. Fifty (92,6 %) patients were able to resume oral diet with a duration of nasogastric tube feeding of 7–35 days. Three-year overall/disease-specific survival for the whole cohort were 47 and 51,1 %, for p16-positive (22 %) cohort – 65,6 and 87,5 %, for p16-negative (78 %) cohort – 40,6 and 46,8 %. Thirteen (24 %) patients developed a local recurrence. The rate of local recurrence was negatively affected by p16 negativity (p = 0,048), depth of invasion &gt;10 mm (p = 0,044) and depth of invasion &gt;15 mm (p = 0,003).</p><p><bold>Conclusion.</bold> Transhyoid approach may be considered as a surgical option for treatment of oropharyngeal carcinoma with acceptable rate of complications.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель исследования</bold> – анализ онкологических и функциональных результатов хирургического лечения рака ротоглотки с применением чресподъязычного доступа.</p><p><bold> Материалы и методы.</bold> Проанализированы данные о 55 пациентах с раком ротоглотки (T1 – 6 случаев, T2 – 16, T3 – 19, T4 – 14), при хирургическом лечении которых использован чресподъязычный доступ. Данные получены из протоколов операций, историй болезни, документации поликлинического отделения и регионального канцер-регистра. Оценивали частоту осложнений в послеоперационном периоде, характер прогрессирования заболевания, включая все случаи местного рецидива. Для изучения корреляции между факторами опухоли и факторами, характеризующими хирургическое лечение (осложнения в послеоперационном периоде, способ реконструкции), был использован однофакторный анализ с применением теста χ2 и точного теста Фишера. Влияние факторов опухоли и характера лечения (категория Т, степень дифференцировки, периневральное распространение, уровень экспрессии р16, глубина инвазии, распространение опухоли на ротовую полость, адъювантное лечение) на частоту возникновения местных рецидивов исследовано таким же образом. Различия в показателях выживаемости оценивали с помощью логрангового критерия. Результаты сравнивали с данными научной литературы.</p><p><bold>Результаты.</bold> У 17 (30,9 %) пациентов развились 29 осложнений в послеоперационном периоде. Послеоперационная летальность составила 1,8 %. В 5 (9,1 %) случаях потребовались повторные оперативные вмешательства. Способ реконструкции оказался самым значимым фактором, увеличивающим частоту осложнений с 9,5 % при первичном шве раны глотки до 42,4 % при использовании лоскутов (р = 0,014). Возобновили пероральный прием пищи 50 (92,6 %) пациентов в среднем через 15,2 дня после операции. Общая и специфическая 3-летняя выживаемость составила 47 и 51,1 %, в группе пациентов с р16-позитивными (22 %) опухолями – 65,6 и 87,5 %, у пациентов с р16-негативными (78 %) опухолями – 40,6 и 46,8 %. У 13 (24 %) пациентов возник местный рецидив. На риск возникновения местного рецидива оказали влияние следующие факторы: р16-негативный статус (р = 0,048), глубина инвазии &gt;10 мм (р = 0,044) и глубина инвазии &gt;15 мм (р = 0,003).</p><p><bold>Заключение.</bold> Чресподъязычный доступ может рассматриваться как один из вариантов доступа при хирургическом лечении рака ротоглотки.</p></trans-abstract><kwd-group xml:lang="en"><kwd>oropharyngeal carcinoma</kwd><kwd>transhyoid approach</kwd><kwd>survival</kwd><kwd>complications</kwd><kwd>recurrence</kwd><kwd>death rate</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>орофарингеальный рак</kwd><kwd>чресподъязычный доступ</kwd><kwd>выживаемость</kwd><kwd>осложнения</kwd><kwd>рецидивы</kwd><kwd>летальность</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Trotter W. A method of lateral pharyngotomy for the exposure of large growths of the epilaryngeal region. Proceedings of the Royal Society of Medicine 1920;13(Laryngol Sect):196–8.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Laccourreye O., Benito J., Menard M. et al. Lateral pharyngotomy for selected invasive squamous cell carcinoma of the lateral oropharynx. Part I: How. Laryngoscope 2013;123(11):2712–7. DOI: 10.1002/lary.24161.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Agrawal A., Wenig B.L. Resection of cancer of the tongue base and tonsil via the transhyoid approach. Laryngoscope 2000;110(11):1802–6. DOI: 10.1097/00005537-200011000-00005.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Nasri S., Oh Y., Calcaterra T.C. Transpharyngeal approach to base of tongue tumors: a comparative study. Laryngoscope 1996;106(8):945–50. DOI: 10.1097/00005537-199608000- 00006.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Masuda M., Fukushima J., Kadota H. et al. Mandible preserving pull-through oropharyngectomy for advanced oropharyngeal cancer: a pilot study. Auris Nasus Larynx 2011;38(3):392–7. DOI: 10.1016/j.anl.2010.08.010.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Shah J.P., Patel S.G., Singh B. Pharynx and esophagus. In: Shah J.P., Patel S.G., Singh B. Jatin Shah’s head and neck sugery and oncology. 4th edn. Philadelphia: Elsevier, 2012. P. 309.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sobin L.H., Gospodarowicz M.K., Wittekind C. TNM classification of malignant tumors. 7th edn. Oxford: Wiley, 2009.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Pelliccia P., Del Pero M.M., Mercier G. et al. Mini-invasive lateral oropharyngectomy for T3–T4a oropharyngeal cancer. Eur Arch Otorhinolaryngol 2013;270(4):1419–25. DOI: 10.1007/s00405-012-2158-5.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bertolin A., Ghirardo G., Lionello M. et al. Lateral pharyngotomy approach in the treatment of oropharyngeal carcinoma. Eur Arch Otorhinolaryngol 2017;274(6):2573–80. DOI: 10.1007/s00405-017-4538-3.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Roux M., Dassonville O., Ettaiche M. et al. Transoral-transcervical oropharyngectomy without mandibulotomy, associated to fasciocutaneous radial forearm free-flap reconstruction, for oropharyngeal cancer: Postoperative course, oncologic and functional results, and prognostic factors. Eur Ann Otorhinolaryngol Head Neck Dis 2017;134(2):71–6. DOI: 10.1016/j.anorl.2016.11.004.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Rodrigo J.P., Díaz-Molina J.P., Moreno C. et al. Oncologic and functional results after transhyoid surgical approach for cancer of the base of tongue. Head Neck 2011;33(8):1079–84. DOI: 10.1002/hed.21569.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Zhang X., Li M.J., Fang Q.G. et al. A comparison between the pectoralis major myocutaneous flap and the free anterolateral thigh perforator flap for reconstruction in head and neck cancer patients: assessment of the quality of life. J Craniofacial Surg 2014;25(3):868–71. DOI: 10.1097/SCS.0000000000000443.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Geiger E.J., Basques B.A., Chang C.C. et al. Pedicle versus free flap reconstruction in patients receiving intraoperative brachytherapy. J Plast Surg Hand Surg 2016;50(4):227–32. DOI: 10.3109/2000656X.2016.1152974.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Zafereo M.E., Weber R.S., Lewin J.S. et al. Complications and functional outcomes following complex oropharyngeal reconstruction. Head Neck 2010;32(8):1003–11. DOI: 10.1002/hed.21290.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Bhayani M.K., Hutcheson K.A., Barringer D.A. et al. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck 2013;35(11):1634–40. DOI: 10.1002/hed.23200.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ibrahim A.S., Civantos F.J., Leibowitz J.M. et al. Meta-analysis comparing outcomes of different transoral surgical modalities in management of oropharyngeal carcinoma. Head Neck 2019;41(6):1656–66. DOI: 10.1002/hed.25647.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Brickman D., Gross N.D. Robotic approaches to the pharynx: tonsil cancer. Otolaryngol Clin North Am 2014;47(3):359–72. DOI: 10.1016/j.otc.2014.03.002.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Poon H., Li C., Gao W. et al. Evolution of robotic systems for transoral head and neck surgery. Vol. 87. Elsevier, 2018. Pp. 82–88. DOI: 10.1016/j.oraloncology.2018.10.020.</mixed-citation></ref></ref-list></back></article>
